FTC’s Crackdown on Pharma Mergers Reflects ‘Tougher’ M&A Environment Under Biden Administration: Lawyer
March 22, 2021
By: Eric Sagonowsky
FiercePharma
Axinn partner Jeny Maier was quoted in the FiercePharma article, "FTC's Crackdown on Pharma Mergers Reflects 'Tougher' M&A Environment Under Biden Administration: Lawyer." This quote also appeared in the April 21, 2021 Forbes article, “After Roaring in 2020, Biotech Stocks Now Weighed Down By Merger Scrutiny, FDA Approval Delays and Possible Drug Pricing Legislation.”
Click here to access the article.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
IBA Annual Conference 2025
Speaking Engagement
Antitrust
Thomson Reuters 24th Annual Law Firm COO & CFO Forum
Speaking Engagement
LegalNEXT 2025
Speaking Engagement
Antitrust
Informa Antitrust Texas 2025
Speaking Engagement
Antitrust
ACI Forum on Pharma & Biotech Patent Litigation USA 2025
Speaking Engagement
Intellectual Property
MCCA Gala 2025
Sponsorship
Antitrust
Antitrust 101: Trial-Minded Antitrust Discovery
Webinar
Antitrust
ABA Antitrust Plaintiffs' Roundtable 2025
Speaking Engagement
Antitrust
Centerforce IP Strategy Summit: Palo Alto
Speaking Engagement
Intellectual Property
Corporate Counsel Women, Influence, & Power in Law Conference 2025
Speaking Engagement
Antitrust